Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Swanstrom

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Current Opinion in Biotechnology|August 1, 1994
Characterization of HIV-1 protease mutants: random, directed, selectedR Swanstrom
Pharmacology & Therapeutics|May 9, 2000
Human immunodeficiency virus type-1 protease inhibitors: therapeutic successes and failures, suppression and resistanceR Swanstrom, J Erona
Current Topics in Microbiology and Immunology|January 1, 1990
Retrovirus envelope glycoproteinsE Hunter, R Swanstrom
Virology|November 21, 2007
Development and characterization of a new single cycle vaccine vector in the simian immunodeficiency virus model systemY Tang, R Swanstrom
Biomedica Biochimica Acta|January 1, 1991
The HIV-1 gag precursor is processed via two pathways: implications for cytotoxicityA H Kaplan, R Swanstrom
AIDS Research and Human Retroviruses|March 11, 1991
Characterization of an HIV-1 isolate displaying an apparent absence of virion-associated reverse transcriptase activityR W Buckheit, R Swanstrom
Journal of Virology|December 1, 1985
A new pathway in the generation of defective retrovirus DNAJ C Olsen, R Swanstrom
Analytical Biochemistry|May 1, 1978
X-ray intensifying screens greatly enhance the detection by autoradiography of the radioactive isotopes 32P and 125IR Swanstrom, P R Shank
Proceedings of the National Academy of Sciences of the United States of America|May 15, 1991
Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartmentsA H Kaplan, R Swanstrom
Journal of Virology|September 1, 1993
V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variabilityL Milich, B Margolin, R Swanstrom
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Current Opinion in Biotechnology|August 1, 1994
Characterization of HIV-1 protease mutants: random, directed, selectedR Swanstrom
Pharmacology & Therapeutics|May 9, 2000
Human immunodeficiency virus type-1 protease inhibitors: therapeutic successes and failures, suppression and resistanceR Swanstrom, J Erona
Current Topics in Microbiology and Immunology|January 1, 1990
Retrovirus envelope glycoproteinsE Hunter, R Swanstrom
Virology|November 21, 2007
Development and characterization of a new single cycle vaccine vector in the simian immunodeficiency virus model systemY Tang, R Swanstrom
Biomedica Biochimica Acta|January 1, 1991
The HIV-1 gag precursor is processed via two pathways: implications for cytotoxicityA H Kaplan, R Swanstrom
AIDS Research and Human Retroviruses|March 11, 1991
Characterization of an HIV-1 isolate displaying an apparent absence of virion-associated reverse transcriptase activityR W Buckheit, R Swanstrom
Journal of Virology|December 1, 1985
A new pathway in the generation of defective retrovirus DNAJ C Olsen, R Swanstrom
Analytical Biochemistry|May 1, 1978
X-ray intensifying screens greatly enhance the detection by autoradiography of the radioactive isotopes 32P and 125IR Swanstrom, P R Shank
Proceedings of the National Academy of Sciences of the United States of America|May 15, 1991
Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartmentsA H Kaplan, R Swanstrom
Journal of Virology|September 1, 1993
V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variabilityL Milich, B Margolin, R Swanstrom
Pageof 9